Evidence map›Paper›PMID 30381765›Full record

ArticleJNMA; journal of the Nepal Medical Association

Molecular Confirmation of G1138A Mutation in FGFR gene in Achondroplasia.

Shyam Bahadur Khanal, Mitesh Shrestha, Hemanta Kumari Chaudhary, Smita Shrestha, Rohit Kumar Pokharel

Open access · diamondAbstract read
In one paragraph

Article in JNMA; journal of the Nepal Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Shyam Bahadur KhanalCentral Department of Biotechnology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Mitesh ShresthaNepal Academy of Science and Technology, Khumaltar, Lalitpur, Nepal.
Hemanta Kumari ChaudharyCenter for Molecular Dynamics- Nepal, Swaraj Sadan, Prasutigriha Marg, Thapathali-11, Kathmandu, Nepal.
Smita ShresthaCentral Department of Biotechnology, Tribhuvan University, Kirtipur, Kathmandu, Nepal.
Rohit Kumar PokharelInstitute of Medicine, Maharajgunj Medicine Campus, Tribhuvan University, Maharajgunj, Kathmandu, Nepal.
Tribhuvan University · NPCenter for Molecular Dynamics - Nepal · NPNepal Academy of Science and Technology · NPTribhuvan University Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAchondroplasia is the most common form of skeletal dysplasia of genetic origin in humans which is characterized by disproportionate rhizomelic dwarfism. Heterozygous mutation in the transmembrane domain of the FGFR3 gene (4p16.3) occurs as a de novo mutation in most of the cases.

methodsDNA was isolated from seven samples, out of which, five had clinical features of Achondroplasia while one was dwarf but did not show symptoms of the disorder and one as negative control. PCR was performed for the region incorporating the hotspot region viz. 1138th nucleotide. PCR amplicon of size 164 bp was obtained from all the samples, and was sequenced.

resultsSequence analysis showed the presence of mutation (G to A transition) in all of the five samples. The five samples that showed the clinical features of Achondroplasia had mutation in the region being analyzed while the single patient who had no clinical manifestations of the disorder despite being dwarf had no such mutation. Among the five patients studied, one patient had a family history of Achondroplasia as observed through pedigree analysis while the remaining four cases were sporadic in nature.

conclusionsThis study further supports that the G1138A mutation is the one of the most common point mutation among Achondroplasia cases. Genetic diagnosis can be useful to identify the disease prenatally and differentiate other life threatening dwarfism for the safety of both mother and fetus.

Indexed as

AchondroplasiaAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedNepalPoint MutationReceptor, Fibroblast Growth Factor, Type 3Sequence AnalysisSymptom AssessmentFGFR3 protein, humanReceptor, Fibroblast Growth Factor, Type 3achondroplasia; dwarfism; fibroblast growth factor receptor 3; point Mutation.

Identifiers

PMID30381765
PMCPMC8997281
OpenAlexW2893140195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.